Global Thrombosis Drugs Market 2024-2028

The thrombosis drugs market is forecasted to grow by USD 17018.4 mn during 2023-2028, accelerating at a CAGR of 10.03% during the forecast period. The report on the thrombosis drugs market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by introduction of novel oral anticoagulants, growing prevalence of coagulation disorders, and growing awareness of cardiac care.

Market Scope
Base Year	2024
End Year	2028
Series Year	2024-2028
Growth Momentum	Accelerate
YOY 2024	8.88%
CAGR	10.03%
Incremental Value	$17018.4 mn

Technavio's thrombosis drugs market is segmented as below:

By Indication

Pulmonary embolism
DVT

By Geographical Landscape

North America
Europe
Asia
Rest of World (ROW)

This study identifies the sedentary lifestyle as one of the prime reasons driving the thrombosis drugs market growth during the next few years. Also, high prevalence of thrombosis and advent of anticoagulant antidotes will lead to sizable demand in the market.

The report on the thrombosis drugs market covers the following areas:

Thrombosis drugs market sizing
Thrombosis drugs market forecast
Thrombosis drugs market industry analysis

The vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading thrombosis drugs market vendors that include Aspen Pharmacare Holdings Ltd., AuroMedics Pharma LLC, Baxter International Inc., Bayer AG, Biogen Inc., Boehringer Ingelheim International GmbH, Bristol Myers Squibb Co., Daiichi Sankyo Co. Ltd., F. Hoffmann La Roche Ltd., GlaxoSmithKline PLC, GoodRx Holdings Inc., Grifols SA, Inari Medical Inc., Italfarmaco Holding SPA, Johnson and Johnson Services Inc., Pfizer Inc., Sanofi SA, Vasudha Pharma Chem Ltd., and Viatris Inc.. Also, the thrombosis drugs market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The companies presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Product Code: IRTNTR73016

1 Executive Summary

1.1 Market overview
- Executive Summary - Chart on Market Overview
- Executive Summary - Data Table on Market Overview
- Executive Summary - Chart on Global Market Characteristics
- Executive Summary - Chart on Market By Geographical Landscape
- Executive Summary - Chart on Market Segmentation by Indication
- Executive Summary - Chart on Incremental Growth
- Executive Summary - Data Table on Incremental Growth
- Executive Summary - Chart on Company Market Positioning

2 Market Landscape

2.1 Market ecosystem
- Parent Market
- Data Table on - Parent Market
2.2 Market characteristics
- Market characteristics analysis
2.3 Value chain analysis
- Value Chain Analysis

3 Market Sizing

3.1 Market definition
- Offerings of companies included in the market definition
3.2 Market segment analysis
- Market segments
3.3 Market size 2023
3.4 Market outlook: Forecast for 2023-2028
- Chart on Global - Market size and forecast 2023-2028 ($ million)
- Data Table on Global - Market size and forecast 2023-2028 ($ million)
- Chart on Global Market: Year-over-year growth 2023-2028 (%)
- Data Table on Global Market: Year-over-year growth 2023-2028 (%)

4 Historic Market Size

4.1 Global Thrombosis Drugs Market 2018 - 2022
- Historic Market Size - Data Table on Global Thrombosis Drugs Market 2018 - 2022 ($ million)
4.2 Indication segment analysis 2018 - 2022
- Historic Market Size - Indication Segment 2018 - 2022 ($ million)
4.3 Geography segment analysis 2018 - 2022
- Historic Market Size - Geography Segment 2018 - 2022 ($ million)
4.4 Country segment analysis 2018 - 2022
- Historic Market Size - Country Segment 2018 - 2022 ($ million)

5 Five Forces Analysis

5.1 Five forces summary
- Five forces analysis - Comparison between 2023 and 2028
5.2 Bargaining power of buyers
- Bargaining power of buyers - Impact of key factors 2023 and 2028
5.3 Bargaining power of suppliers
- Bargaining power of suppliers - Impact of key factors in 2023 and 2028
5.4 Threat of new entrants
- Threat of new entrants - Impact of key factors in 2023 and 2028
5.5 Threat of substitutes
- Threat of substitutes - Impact of key factors in 2023 and 2028
5.6 Threat of rivalry
- Threat of rivalry - Impact of key factors in 2023 and 2028
5.7 Market condition
- Chart on Market condition - Five forces 2023 and 2028

6 Market Segmentation by Indication

6.1 Market segments
- Chart on Indication - Market share 2023-2028 (%)
- Data Table on Indication - Market share 2023-2028 (%)
6.2 Comparison by Indication
- Chart on Comparison by Indication
- Data Table on Comparison by Indication
6.3 Pulmonary embolism - Market size and forecast 2023-2028
- Chart on Pulmonary embolism - Market size and forecast 2023-2028 ($ million)
- Data Table on Pulmonary embolism - Market size and forecast 2023-2028 ($ million)
- Chart on Pulmonary embolism - Year-over-year growth 2023-2028 (%)
- Data Table on Pulmonary embolism - Year-over-year growth 2023-2028 (%)
6.4 DVT - Market size and forecast 2023-2028
- Chart on DVT - Market size and forecast 2023-2028 ($ million)
- Data Table on DVT - Market size and forecast 2023-2028 ($ million)
- Chart on DVT - Year-over-year growth 2023-2028 (%)
- Data Table on DVT - Year-over-year growth 2023-2028 (%)
6.5 Market opportunity by Indication
- Market opportunity by Indication ($ million)
- Data Table on Market opportunity by Indication ($ million)

7 Customer Landscape

7.1 Customer landscape overview
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

8 Geographic Landscape

8.1 Geographic segmentation
- Chart on Market share By Geographical Landscape 2023-2028 (%)
- Data Table on Market share By Geographical Landscape 2023-2028 (%)
8.2 Geographic comparison
- Chart on Geographic comparison
- Data Table on Geographic comparison
8.3 North America - Market size and forecast 2023-2028
- Chart on North America - Market size and forecast 2023-2028 ($ million)
- Data Table on North America - Market size and forecast 2023-2028 ($ million)
- Chart on North America - Year-over-year growth 2023-2028 (%)
- Data Table on North America - Year-over-year growth 2023-2028 (%)
8.4 Europe - Market size and forecast 2023-2028
- Chart on Europe - Market size and forecast 2023-2028 ($ million)
- Data Table on Europe - Market size and forecast 2023-2028 ($ million)
- Chart on Europe - Year-over-year growth 2023-2028 (%)
- Data Table on Europe - Year-over-year growth 2023-2028 (%)
8.5 Asia - Market size and forecast 2023-2028
- Chart on Asia - Market size and forecast 2023-2028 ($ million)
- Data Table on Asia - Market size and forecast 2023-2028 ($ million)
- Chart on Asia - Year-over-year growth 2023-2028 (%)
- Data Table on Asia - Year-over-year growth 2023-2028 (%)
8.6 Rest of World (ROW) - Market size and forecast 2023-2028
- Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
- Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
- Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
- Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
8.7 US - Market size and forecast 2023-2028
- Chart on US - Market size and forecast 2023-2028 ($ million)
- Data Table on US - Market size and forecast 2023-2028 ($ million)
- Chart on US - Year-over-year growth 2023-2028 (%)
- Data Table on US - Year-over-year growth 2023-2028 (%)
8.8 France - Market size and forecast 2023-2028
- Chart on France - Market size and forecast 2023-2028 ($ million)
- Data Table on France - Market size and forecast 2023-2028 ($ million)
- Chart on France - Year-over-year growth 2023-2028 (%)
- Data Table on France - Year-over-year growth 2023-2028 (%)
8.9 Norway - Market size and forecast 2023-2028
- Chart on Norway - Market size and forecast 2023-2028 ($ million)
- Data Table on Norway - Market size and forecast 2023-2028 ($ million)
- Chart on Norway - Year-over-year growth 2023-2028 (%)
- Data Table on Norway - Year-over-year growth 2023-2028 (%)
8.10 UK - Market size and forecast 2023-2028
- Chart on UK - Market size and forecast 2023-2028 ($ million)
- Data Table on UK - Market size and forecast 2023-2028 ($ million)
- Chart on UK - Year-over-year growth 2023-2028 (%)
- Data Table on UK - Year-over-year growth 2023-2028 (%)
8.11 Japan - Market size and forecast 2023-2028
- Chart on Japan - Market size and forecast 2023-2028 ($ million)
- Data Table on Japan - Market size and forecast 2023-2028 ($ million)
- Chart on Japan - Year-over-year growth 2023-2028 (%)
- Data Table on Japan - Year-over-year growth 2023-2028 (%)
8.12 Market opportunity By Geographical Landscape
- Market opportunity By Geographical Landscape ($ million)
- Data Tables on Market opportunity By Geographical Landscape ($ million)

9 Drivers, Challenges, and Opportunity/Restraints

9.1 Market drivers
9.2 Market challenges
9.3 Impact of drivers and challenges
- Impact of drivers and challenges in 2023 and 2028
9.4 Market opportunities/restraints

10 Competitive Landscape

10.1 Overview
10.2 Competitive Landscape
- Overview on criticality of inputs and factors of differentiation
10.3 Landscape disruption
- Overview on factors of disruption
10.4 Industry risks
- Impact of key risks on business

11 Competitive Analysis

11.1 Companies profiled
- Companies covered
11.2 Market positioning of companies
- Matrix on companies position and classification
11.3 Aspen Pharmacare Holdings Ltd.
- Aspen Pharmacare Holdings Ltd. - Overview
- Aspen Pharmacare Holdings Ltd. - Business segments
- Aspen Pharmacare Holdings Ltd. - Key offerings
- Aspen Pharmacare Holdings Ltd. - Segment focus
11.4 Baxter International Inc.
- Baxter International Inc. - Overview
- Baxter International Inc. - Business segments
- Baxter International Inc. - Key news
- Baxter International Inc. - Key offerings
- Baxter International Inc. - Segment focus
11.5 Boehringer Ingelheim International GmbH
- Boehringer Ingelheim International GmbH - Overview
- Boehringer Ingelheim International GmbH - Product / Service
- Boehringer Ingelheim International GmbH - Key news
- Boehringer Ingelheim International GmbH - Key offerings
11.6 Bristol Myers Squibb Co.
- Bristol Myers Squibb Co. - Overview
- Bristol Myers Squibb Co. - Product / Service
- Bristol Myers Squibb Co. - Key news
- Bristol Myers Squibb Co. - Key offerings
11.7 Daiichi Sankyo Co. Ltd.
- Daiichi Sankyo Co. Ltd. - Overview
- Daiichi Sankyo Co. Ltd. - Product / Service
- Daiichi Sankyo Co. Ltd. - Key news
- Daiichi Sankyo Co. Ltd. - Key offerings
11.8 F. Hoffmann La Roche Ltd.
- F. Hoffmann La Roche Ltd. - Overview
- F. Hoffmann La Roche Ltd. - Business segments
- F. Hoffmann La Roche Ltd. - Key news
- F. Hoffmann La Roche Ltd. - Key offerings
- F. Hoffmann La Roche Ltd. - Segment focus
11.9 GlaxoSmithKline Plc
- GlaxoSmithKline Plc - Overview
- GlaxoSmithKline Plc - Business segments
- GlaxoSmithKline Plc - Key news
- GlaxoSmithKline Plc - Key offerings
- GlaxoSmithKline Plc - Segment focus
11.10 Johnson and Johnson Services Inc.
- Johnson and Johnson Services Inc. - Overview
- Johnson and Johnson Services Inc. - Business segments
- Johnson and Johnson Services Inc. - Key news
- Johnson and Johnson Services Inc. - Key offerings
- Johnson and Johnson Services Inc. - Segment focus
11.11 Pfizer Inc.
- Pfizer Inc. - Overview
- Pfizer Inc. - Product / Service
- Pfizer Inc. - Key news
- Pfizer Inc. - Key offerings
11.12 Sanofi SA
- Sanofi SA - Overview
- Sanofi SA - Business segments
- Sanofi SA - Key news
- Sanofi SA - Key offerings
- Sanofi SA - Segment focus

12 Appendix

12.1 Scope of the report
12.2 Inclusions and exclusions checklist
- Inclusions checklist
- Exclusions checklist
12.3 Currency conversion rates for US$
- Currency conversion rates for US$
12.4 Research methodology
- Research methodology
12.5 Data procurement
- Information sources
12.6 Data validation
- Data validation
12.7 Validation techniques employed for market sizing
- Validation techniques employed for market sizing
12.8 Data synthesis
- Data synthesis
12.9 360 degree market analysis
- 360 degree market analysis
12.10 List of abbreviations
- List of abbreviations